LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

نویسندگان

  • U Mack
  • G B Migliori
  • M Sester
  • H L Rieder
  • S Ehlers
  • D Goletti
  • A Bossink
  • K Magdorf
  • C Hölscher
  • B Kampmann
  • S M Arend
  • A Detjen
  • G Bothamley
  • J P Zellweger
  • H Milburn
  • R Diel
  • P Ravn
  • F Cobelens
  • P J Cardona
  • B Kan
  • I Solovic
  • R Duarte
  • D M Cirillo
چکیده

Tuberculosis control relies on the identification and preventive treatment of individuals who are latently infected with Mycobacterium tuberculosis. However, direct identification of latent tuberculosis infection is not possible. The diagnostic tests used to identify individuals latently infected with M. tuberculosis, the in vivo tuberculin skin test and the ex vivo interferon-gamma release assays (IGRAs), are designed to identify an adaptive immune response against, but not necessarily a latent infection with, M. tuberculosis. The proportion of individuals who truly remain infected with M. tuberculosis after tuberculin skin test or IGRA conversion is unknown. It is also uncertain how long adaptive immune responses towards mycobacterial antigens persist in the absence of live mycobacteria. Clinical management and public healthcare policies for preventive chemotherapy against tuberculosis could be improved, if we were to gain a better understanding on M. tuberculosis latency and reactivation. This statement by the TBNET summarises knowledge and limitations of the currently available tests used in adults and children for the diagnosis of latent tuberculosis infection. In summary, the main issue regarding testing is to restrict it to those who are known to be at higher risk of developing tuberculosis and who are willing to accept preventive chemotherapy.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Internal consistency of reference equations.

1 Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 2010; 36: 1185–1206. 2 Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956–973. 3 Diel R, Goletti D, F...

متن کامل

Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.

clinical disease state and effect of treatment. J Immunol 2001; 167: 5217–5225. 3 Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004; 38: 754–756. 4 Kobashi Y, Mouri K, Fukuda M, et al. Transitional change in the clinical features of pulmonary tuberculosis. Respiration 2008; 75: 304–309. 5 Bosshard V,...

متن کامل

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

Anti-tumour necrosis factor (TNF) monoclonal antibodies or soluble TNF receptors have become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. Individuals who are treated with TNF antagonists are at an increased risk of reactivating latent infections, especially tuberculosis (TB). Following TNF antagonist thera...

متن کامل

Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach.

We read with interest the TBNET consensus statement on the diagnosis and treatment of tuberculosis (TB) in patients screened for tumour necrosis factor (TNF)-a antagonist therapy [1]. Admittedly, accumulated evidence during the last decade demonstrates that adherence to such guidelines has minimised the risk of TB reactivation in patients receiving immunosuppressive regimens, including anti-TNF...

متن کامل

Phenotyping chronic pulmonary aspergillosis by cluster analysis.

References 1 Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014; 27: 3–20. 2 Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88–99. 3 Sester M, van Leth F, ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The European respiratory journal

دوره 33 5  شماره 

صفحات  -

تاریخ انتشار 2009